Borrelia Infections: Clinical Trials

14 trials for Borrelia Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 14 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 10, Terminated 2, Active not recruiting 1, Recruiting 1
Phase 22Completed 2

Follow Borrelia Infections: new trials by email Literature Review of Borrelia Infections trials Research Report on Borrelia Infections

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
VLA15, Placebo - Lyme Disease
Phase 3RecruitingPfizer17122026-04-082026-05-06
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
VLA15, Placebo - Lyme Borreliosis
Phase 3Active not recruitingPfizer2072025-11-192026-05-06
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
VLA15, Normal Saline - Lyme Disease
Phase 3CompletedPfizer35472022-12-122026-05-07
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
VLA15, Saline - Lyme Disease
Phase 3CompletedPfizer125462022-08-042026-06-04
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
RLP, Placebo - Post-Lyme Disease Syndrome (PLDS)
Phase 2 / Phase 3CompletedOptimal Health Research1002019-11-292021-04-12
Symptomatic Management of Lyme Arthritis
Naproxen, Acetaminophen - Lyme Arthritis, Lyme Disease
Phase 3TerminatedDesiree Neville, MD32019-10-012025-11-17
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
Doxycycline, Placebo - Neuroborreliosis, Borrelia Burgdorferi
Phase 3CompletedSorlandet Hospital HF1212015-10-012024-01-23
Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
Permethrin, Placebo - Lyme Disease
Phase 3TerminatedUniversity of Minnesota612008-06-012020-06-04
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
Ceftriaxone, Doxycycline - Lyme Neuroborreliosis
Phase 3CompletedSorlandet Hospital HF1202004-03-012023-05-06
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
doxycycline treatment - Relapsing Fever, Tick-borne, Jarisch Herxheimer Reaction
Phase 2 / Phase 3CompletedMedical Corps, Israel Defense Force1402002-04-012024-12-19
Lyme Disease Prevention Program
Education about disease prevention - Lyme Disease, Tick-Borne Diseases
Phase 3CompletedBrigham and Women's Hospital200001997-04-012013-12-24
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
ceftriaxone, doxycycline - Lyme Disease
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)662010-08-27
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
ceftriaxone, doxycycline - Lyme Disease
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1942010-08-27
Study and Treatment of Post Lyme Disease (STOP-LD)
Antibiotics - Lyme Disease
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)552010-08-27

Narrower conditions

Lyme Disease (10)  ·  Lyme Neuroborreliosis (3)  ·  Arthritis (1)  ·  Post-Lyme Disease Syndrome (1)  ·  Relapsing Fever (1)  ·  Tick-Borne Diseases (1)  ·  Vector Borne Diseases (1)

Broader conditions

Bacterial Infections (14)  ·  Bacterial Infections and Mycoses (14)  ·  Gram-Negative Bacterial Infections (14)  ·  Infections (14)  ·  Spirochaetales Infections (14)  ·  Tick-Borne Diseases (13)  ·  Vector Borne Diseases (13)  ·  Central Nervous System Bacterial Infections (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Infections (3)  ·  Lyme Disease (3)  ·  Nervous System Diseases (3)  ·  Chronic Disease (1)  ·  Disease Attributes (1)

Interventions

Doxycycline (4)  ·  Ceftriaxone (3)  ·  Acetaminophen (1)  ·  Anti-Bacterial Agents (1)  ·  Naproxen (1)  ·  Permethrin (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

Pfizer (4)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Sorlandet Hospital HF (2)  ·  Brigham and Women's Hospital (1)  ·  Desiree Neville, MD (1)  ·  Medical Corps, Israel Defense Force (1)  ·  Optimal Health Research (1)  ·  University of Minnesota (1)

Countries

United States (11)  ·  Canada (2)  ·  Finland (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Anne Marit Solheim, M.D (1)  ·  David R. Boulware, MD, MPH (1)  ·  Desiree NW Neville, MD (1)  ·  Matthew H. Liang, MD, MPH (1)  ·  Tal Hasin, MD (1)

Results publications

PMID 16837678, PMID 18567539, PMID 38262807

NIH funding

2015 (1), 2023 (1), 2025 (1), P60AR036308 (1), R01AI031561 (1)